Pathway
Regulatory T cells (IL-2 / Treg axis)
Regulatory T cells (Tregs) keep the immune system in balance and prevent autoimmunity. Low-dose, Treg-selective IL-2 conjugates aim to expand Tregs preferentially over effector cells to re-establish tolerance in autoimmune diseases such as alopecia areata.
1
Drugs
1
Trials tracked
0
Resolved
1
Indications
Drugs hitting this target
Trials targeting Treg / IL-2
1 benchmarkIndications
About Treg / IL-2
What is Treg / IL-2?
Regulatory T cells (Tregs) keep the immune system in balance and prevent autoimmunity. Low-dose, Treg-selective IL-2 conjugates aim to expand Tregs preferentially over effector cells to re-establish tolerance in autoimmune diseases such as alopecia areata.
Which drugs target Treg / IL-2?
Therapies acting on Treg / IL-2 tracked here include Rezpegaldesleukin.